CN | EN
CN | EN

Take the health of patients with liver disease
and liver-related diseases all the way

Provide effective and accessible new treatment
options for liver disease patients in China

Take the health of patients with liver disease and liver-related diseases all the way

Commit ourselves to be a leader in the R&D of innovative drugs
for liver disease and liver-related diseases in China

News

2023-07-31

媒体报道|中国siRNA公司，如何参与功能性治愈乙肝竞争？

近日，动脉新医药访谈了星曜坤泽执行总裁马彦琴女士，文章来源于动脉新医药，作者张钰。     小核酸药物近两年的表现可以用“锋芒毕露”来形容。2022年，小核酸药物公司Sarepta全年的净产...

Read more
2023-05-24

Hepa Thera Announces First CHB Patient Dosed in HT-101 (Its siRNA Product) Phase 1b Part

ThisweekSuzhouHepaTheraBiotechCo.,LtdenrolledthefirstchronichepatitisBpatientinBeijingFriendshipHosp...

Read more
2022-11-24

First subject administration with the first domestic GalNAc-siRNA product for hepatitis B treatment

OnNovember23,2022,thefirstdomesticGalNAc-siRNAproduct-HT-101InjectionforhepatitisBtreatmentdevelope...

Read more
2022-10-09

Hepa Thera, an innovative drug R&D platform focusing on liver diseases, is hatched and established, and finishes the seed round financing

Recently,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaTheraBio.),aninnovativedrugR&Dplatformfocu...

Read more
2022-10-09

Hepa Thera finishes angel round financing, focusing on building a new liver disease treatment platform

Recently,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera)completedtheangelroundfinancingofRMB30m...

Read more
2022-10-09

A hope for patients with chronic hepatitis B - Hepa Thera submits pre-IND application for domestic hepatitis B siRNA drug!

Recently,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera),aninnovativeplatformcompanyforliverdise...

Read more
2022-10-09

A hope for patients with chronic hepatitis B - Hepa Thera’s IND application for domestic hepatitis B siRNA drug is accepted!

SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera)isaninnovativeplatformcompanyforliverdiseasetrea...

Read more
2022-10-09

A hope for patients with chronic hepatitis B - Hepa Thera submits pre-IND application for domestic hepatitis B surface antigen neutralizing antibody (HT-102)

Thisweek,SuzhouHepaTheraBiopharmaceuticalCo.,Ltd.(HepaThera),aninnovativeplatformcompanyforliverdis...

Read more